Find information on thousands of medical conditions and prescription drugs.

Optic atrophy

Optic atrophy is the loss of some or most of the fibers of the optic nerve . In medicine, "atrophy" usually means "shrunken but capable of regrowth", so some argue that "optic atrophy" as a pathological term and somewhat misleading and use "optic neuropathy" instead. The optic nerve is part of the brain and has no capability for regeneration. Hence, there can be no recovery from optic atrophy and the term may refer to serious or mild, but always irreversible visual loss due to damage to the optic nerve. There may be symptoms associated with loss of vision (although there may be a particular difficulty with colour vision). Optic atrophy can be congenital or acquired. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Obesity
Obsessive-compulsive...
Occipital horn syndrome
OCD
Ochronosis
Oculocutaneous albinism,...
Oculopharyngeal muscular...
Odontophobia
Odynophobia
Oikophobia
Olfactophobia
Olivopontocerebellar atrophy
Omenn syndrome
Onchocerciasis
Oncocytoma
Ondine's curse
Opportunistic infections
Oppositional defiant...
Optic atrophy
Optic neuritis
Oral leukoplakia
Ornithosis
Orthostatic intolerance
Osgood-Schlatter disease
Osteitis deformans
Osteoarthritis
Osteochondritis
Osteochondritis dissecans
Osteochondroma
Osteogenesis Imperfecta
Osteomalacia
Osteomyelitis
Osteopetrosis, (generic...
Osteoporosis
Osteosclerosis
Otosclerosis
Otospondylomegaepiphyseal...
Ovarian cancer
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

If congenital, it is usually hereditary with an onset of deterioration in childhood and may be accompanied by nystagmus. Leber's Hereditary Optic Neuropathy, (LHON) or Leber Optic Atrophy is hereditary, but typically has its onset in 20-30 year old males. This is due to a mutation of the mitochondrial genome and hence is passed exclusively through the mothers. Alternatively, congenital optic atrophy can be caused by a lack of oxygen during pregnancy, labour or in the early days of a child's life. Some drugs taken during pregnancy are also associated with optic atrophy.

The acquired type of optic atrophy may be due to blood supply changes in the eye or optic nerve (anterior ischemic optic neuropathy or posterior ischemic optic neuropathy), may be secondary to inflammation or swelling within the optic nerve (optic neuritis), may be a result of pressure against the optic nerve (such as from a tumour), or may be related to metabolic diseases (e.g., diabetes), trauma, glaucoma, or toxicity (caused by alcohol, tobacco, or other poisons).

Read more at Wikipedia.org


[List your site here Free!]


A Suprasellar and Intrasellar Lesion
From Archives of Pathology & Laboratory Medicine, 9/1/05 by Lara-Torres, Héctor Ricardo

A 44-year-old man with a 3-year history of bilateral vision deterioration presented for medical attention because of severe retroocular headaches. Physical examination revealed amaurosis of the right eye and temporal field blindness in the left eye; funduscopy showed atrophy of the optic disc borders bilaterally. No other signs or symptoms were present. A computed tomography scan demonstrated a hypodense intrasellar and suprasellar lesion. A Tl-weighted magnetic resonance image revealed a large suprasellar and intrasellar cystic lesion that dorsally displaced and compressed the hypothalamus (Figure 1, arrow). No abnormalities of pituitary hormone levels were apparent. The patient underwent a subfrontal craniotomy, the serous cyst content was drained, and the wall of the cyst was partially excised. The patient died of respiratory failure that developed after the operation.

The autopsy revealed multiple foci of pneumonia as the cause of death. Unfortunately no cultures were performed, so the etiologic agent was not identified. The ventral surface of the brain showed a 5-cm suprasellar cystic cavity that compressed the optic chiasm (Figure 2) and a softening due to a subacute infarction in the territory of both the middle and right anterior cerebral arteries, a change associated with the surgical procedure and more evident in the coronal sections (Figure 3). The hypophysis was not identified grossly. Histologie examination of the cystic lesion revealed a nonstratified cuboidal to columnar ciliated epithelium with round to oval basal nuclei (Figure 4) and some islands of normal adenohypophysis and neurohypophysis. The brain tissue near the cyst showed prominent gliosis.

What is your diagnosis?

Pathologie Diagnosis: Rathke Cleft Cyst

Rathke cleft cysts, such as craniopharyngiomas, are generally believed to originate from remnants of the Rathke pouch, although some authors believe there may be a different origin or that Rathke cysts may originate from the Rathke pouch at a different stage of development.1 Rathke cysts are incidental findings in approximately 33% of routine autopsies.2,3 Rarely, these cysts become large enough to cause symptoms. Since Goldzieher first described the entity in 1913, at least 179 cases have been reported.3-5 They usually present in the fourth or fifth decade of life, and there is a 2:1 female predominance. The most common symptoms are visual field defects, hypopituitarism, and headaches.3-5 On computed tomography scans and magnetic resonance images, the cysts are usually intrasellar and/or suprasellar, without calcifications, and range from hypo-, iso-, or mixed density or intensity, respectively. This last feature is due to the variable amount of mucus in the cyst.6 Tl-weighted images are hyperintense when there is a high content of protein, cholesterol, or mucopolysaccharide in the cyst.5,6 In imaging studies, the main differential diagnosis is cystic craniopharyngioma, cystic or hemorrhagic pituitary adenoma, arachnoid cyst, pars intermedia cyst, ependymal cyst, epidermoid cyst, cysticercosis, empty sella, mucocele, and intrasellar aneurysm.3,5

The cysts may become symptomatic when they attain a diameter of 1 cm. They have a thin wall, and the cyst contents are variable with a serous, mucoid, gelatinous, or motor oil appearance.5,6 The epithelial lining of the cyst is usually cuboidal or columnar and may be ciliated or contain goblet cells. Squamous metaplasia frequently occurs, which has been attributed to proliferating reserve cells beneath the surface epithelium,6 although some authors think that it is a secondary change caused by inflammation.7 When squamous metaplasia is present, it may be difficult to distinguish craniopharyngioma from Rathke cleft cyst, especially in small surgical specimens. Xin et al1 found that cytokeratins 8 and 20 are positive in Rathke cleft cysts and negative in craniopharyngioma. This immunohistochemical profile may be useful diagnostically in difficult cases.

The management of this benign lesion is surgical excision.3-5 Some recurrent cases have been reported, and in some the recurrence was associated with sellar packing with organic materials such as bone, fat, or cartilage.3,4

References

1. Xin W, Rubin MA, Mckeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med. 2002;126:1174-1178.

2. Teramoto A, Hirakawa K, Sanno N, Osamura Y. Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology. 1994;193:1 61-1 64.

3. Kasperbauer JL, Orvidas LJ, Atkinson JLD, Abboud CF. Rathke cleft cyst: diagnostic and therapeutic considerations. Laryngoscope. 2002;112:1836-1 839.

4. Mukherjee JJ, Islam N, Kaltsas G, et al. Clinical, radiological and pathological features of patients with Rathke's cleft cyst: tumors that may recur. J Clin Endocrinol Metab. 1997;82:2357-2362.

5. Voelker JL, Campbell RL, Muller J. Clinical, radiographie, and pathological features of symptomatic Rathke's cleft cysts. J Neurosurg. 1991;74:535-544.

6. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology; 1994:357-359. Atlas of Tumor Pathology, 3rd series, fascicle 10.

7. Hama S, Arita K, Nishisaka T, et al. Changes in the epithelium of Rathke cleft cyst associated with inflammation, j Neurosurg. 2002;96:209-216.

Héctor Ricardo Lara-Torres, MD; David Eduardo Aguirre-Quezada, MD; Laura Craciela Chávez-Macías, MD; Juan E. Olvera-Rabieia, MD

Accepted for publication April 29, 2005.

From the Departments of Neuropathology (Drs Lara-Torres, Chávez-Macías, and Olvera-Rabiela) and Anatomic Pathology (Dr Aguirre-Quezada), Mexico City General Hospital, and Department of Medicine, National University of Mexico, Mexico City, Mexico.

The authors have no relevant financial interest in the products or companies described in this article.

Corresponding author: Juan E. Olvera-Rabiela, MD, Unidad de Patología (310), Hospital General de México, Dr. Balmis 148, México, D. F. 06726 (e-mail: laurachm@prodigy.net.mx).

Reprints not available from the authors.

Copyright College of American Pathologists Sep 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Optic atrophy
Home Contact Resources Exchange Links ebay